{"transactions":[{"id":833869,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-19T20:48:04.000Z","date":"2026-03-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":2117,"price":56.05,"value":118657.85,"ownership":{"direct":true},"balance_after":123314,"source":{"system":"sec-edgar","filing":"0001628280-26-019853","document":"wk-form4_1773953282.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026019853/wk-form4_1773953282.xml","form_type":"4"}},{"id":839162,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2026-03-18T00:45:54.000Z","date":"2026-03-16","kind":"grant","planned":false,"acquired":true,"shares":44600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option grant vests 12/48th on March 16, 2027 and 1/48th on the 16th day of each month thereafter."}],"balance_after":44600,"derivative":{"exercise_price":57.43,"exercise_date":"2027-03-16","expiration_date":"2036-03-15","underlying":"Common Stock","underlying_shares":44600},"source":{"system":"sec-edgar","filing":"0001628280-26-019008","document":"wk-form4_1773794751.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026019008/wk-form4_1773794751.xml","form_type":"4"}},{"id":839161,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-18T00:45:54.000Z","date":"2026-03-16","kind":"grant","planned":false,"acquired":true,"shares":18740,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted March 16, 2026. Price not applicable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person's direct holdings have been adjusted by two shares to correct a previous clerical error."}],"balance_after":125431,"source":{"system":"sec-edgar","filing":"0001628280-26-019008","document":"wk-form4_1773794751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026019008/wk-form4_1773794751.xml","form_type":"4"}},{"id":839160,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-18T00:45:54.000Z","date":"2026-03-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":9945,"price":58.51,"value":581881.95,"ownership":{"direct":true},"balance_after":106691,"source":{"system":"sec-edgar","filing":"0001628280-26-019008","document":"wk-form4_1773794751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026019008/wk-form4_1773794751.xml","form_type":"4"}},{"id":880212,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-27T01:28:58.000Z","date":"2026-02-25","kind":"grant","planned":false,"acquired":true,"shares":2569,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2026, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represents the total number of RSUs earned pursuant to a formula based on core operating margin over three, one-year periods spanning 2023 through 2025 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."}],"balance_after":116638,"source":{"system":"sec-edgar","filing":"0001628280-26-012529","document":"wk-form4_1772155735.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026012529/wk-form4_1772155735.xml","form_type":"4"}},{"id":880211,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-27T01:28:58.000Z","date":"2026-02-25","kind":"grant","planned":false,"acquired":true,"shares":7230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2026, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the total number of RSUs earned pursuant to a formula based on the number and nature of development goals achieved during 2023 through 2025 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."}],"balance_after":114069,"source":{"system":"sec-edgar","filing":"0001628280-26-012529","document":"wk-form4_1772155735.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026012529/wk-form4_1772155735.xml","form_type":"4"}},{"id":880210,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-27T01:28:58.000Z","date":"2026-02-25","kind":"grant","planned":false,"acquired":true,"shares":6683,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the total number of RSUs earned pursuant to a formula based on relative total shareholder return during 2023 through 2025 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2026, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."}],"balance_after":106839,"source":{"system":"sec-edgar","filing":"0001628280-26-012529","document":"wk-form4_1772155735.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026012529/wk-form4_1772155735.xml","form_type":"4"}},{"id":905773,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-14T00:01:49.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":375,"price":54.137,"value":20301.375,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents the shares acquired by the reporting person on April 30, 2025, pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":100156,"source":{"system":"sec-edgar","filing":"0001628280-26-008254","document":"wk-form5_1771027306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026008254/wk-form5_1771027306.xml","form_type":"5"}},{"id":1201339,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2025-03-18T22:19:33.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":38590,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests 12/48th on March 17, 2026 and 1/48th on the 17th day of each month thereafter."}],"balance_after":38590,"derivative":{"exercise_price":71.55,"exercise_date":"2026-03-17","expiration_date":"2035-03-16","underlying":"Common Stock","underlying_shares":38590},"source":{"system":"sec-edgar","filing":"0001048477-25-000029","document":"wk-form4_1742336367.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000029/wk-form4_1742336367.xml","form_type":"4"}},{"id":1201338,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-18T22:19:33.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":16640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted March 17, 2025. Price not applicable."}],"balance_after":99781,"source":{"system":"sec-edgar","filing":"0001048477-25-000029","document":"wk-form4_1742336367.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000029/wk-form4_1742336367.xml","form_type":"4"}},{"id":1201337,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-18T22:19:33.000Z","date":"2025-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":18497,"price":69.44,"value":1284431.68,"ownership":{"direct":true},"balance_after":83141,"source":{"system":"sec-edgar","filing":"0001048477-25-000029","document":"wk-form4_1742336367.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000029/wk-form4_1742336367.xml","form_type":"4"}},{"id":1241458,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-28T00:19:58.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":9367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the total number of RSUs earned pursuant to a formula based on the number and nature of development goals achieved during 2022 through 2024 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represents the total number of RSUs earned pursuant to a formula based on core operating margin over three, one-year periods spanning 2022 through 2024 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."}],"balance_after":101638,"source":{"system":"sec-edgar","filing":"0001048477-25-000019","document":"wk-form4_1740701992.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000019/wk-form4_1740701992.xml","form_type":"4"}},{"id":1241457,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-28T00:19:58.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":9660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2025, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the total number of RSUs earned pursuant to a formula based on the number and nature of development goals achieved during 2022 through 2024 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."}],"balance_after":92271,"source":{"system":"sec-edgar","filing":"0001048477-25-000019","document":"wk-form4_1740701992.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000019/wk-form4_1740701992.xml","form_type":"4"}},{"id":1241456,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-28T00:19:58.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":11040,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the total number of RSUs earned pursuant to a formula based on relative total shareholder return during 2022 through 2024 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2025, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."}],"balance_after":82611,"source":{"system":"sec-edgar","filing":"0001048477-25-000019","document":"wk-form4_1740701992.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000019/wk-form4_1740701992.xml","form_type":"4"}},{"id":1466355,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-07-01T20:19:59.000Z","date":"2024-06-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":588,"price":82.33,"value":48410.04,"ownership":{"direct":true},"balance_after":71571,"source":{"system":"sec-edgar","filing":"0001048477-24-000120","document":"wk-form4_1719865192.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000120/wk-form4_1719865192.xml","form_type":"4"}},{"id":1496978,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2024-05-31T22:28:05.000Z","date":"2024-05-30","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":0,"derivative":{"exercise_price":63.1,"exercise_date":"2014-12-04","expiration_date":"2024-06-03","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001048477-24-000114","document":"wk-form4_1717194476.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000114/wk-form4_1717194476.xml","form_type":"4"}},{"id":1496977,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-31T22:28:05.000Z","date":"2024-05-30","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":75.19,"value":375950.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Trade made pursuant to a 10b5-1 plan executed on August 18, 2023."}],"balance_after":72159,"source":{"system":"sec-edgar","filing":"0001048477-24-000114","document":"wk-form4_1717194476.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000114/wk-form4_1717194476.xml","form_type":"4"}},{"id":1496976,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-31T22:28:05.000Z","date":"2024-05-30","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":63.1,"value":315500.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Trade made pursuant to a 10b5-1 plan executed on August 18, 2023."}],"balance_after":77159,"source":{"system":"sec-edgar","filing":"0001048477-24-000114","document":"wk-form4_1717194476.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000114/wk-form4_1717194476.xml","form_type":"4"}},{"id":1496975,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-31T22:28:05.000Z","date":"2024-04-30","kind":"grant","planned":true,"acquired":true,"shares":300,"price":68.646,"value":20593.8,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents the shares acquired by the reporting person on April 30, 2024, pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":72159,"source":{"system":"sec-edgar","filing":"0001048477-24-000114","document":"wk-form4_1717194476.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000114/wk-form4_1717194476.xml","form_type":"4"}},{"id":1570142,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2024-03-20T00:48:23.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":25540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests 12/48th on March 15, 2025 and 1/48th on the 15th day of each month thereafter."}],"balance_after":25540,"derivative":{"exercise_price":83.87,"exercise_date":"2025-03-15","expiration_date":"2034-03-14","underlying":"Common Stock","underlying_shares":25540},"source":{"system":"sec-edgar","filing":"0001048477-24-000044","document":"wk-form4_1710895692.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000044/wk-form4_1710895692.xml","form_type":"4"}},{"id":1570141,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-20T00:48:23.000Z","date":"2024-03-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":20789,"price":83.87,"value":1743573.43,"ownership":{"direct":true},"balance_after":71859,"source":{"system":"sec-edgar","filing":"0001048477-24-000044","document":"wk-form4_1710895692.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000044/wk-form4_1710895692.xml","form_type":"4"}},{"id":1570140,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-20T00:48:23.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":11400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted March 15, 2024. Price not applicable."}],"balance_after":92648,"source":{"system":"sec-edgar","filing":"0001048477-24-000044","document":"wk-form4_1710895692.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000044/wk-form4_1710895692.xml","form_type":"4"}},{"id":1610646,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-29T22:18:55.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":6103,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2024, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represents the total number of RSUs earned pursuant to a formula based on non-GAAP income over three, one-year periods spanning 2021 through 2023 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."}],"balance_after":81248,"source":{"system":"sec-edgar","filing":"0001048477-24-000028","document":"wk-form4_1709245123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000028/wk-form4_1709245123.xml","form_type":"4"}},{"id":1610645,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-29T22:18:55.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":8802,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2024, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the total number of RSUs earned pursuant to a formula based on the number and nature of strategic goals achieved during 2021 through 2023 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."}],"balance_after":75145,"source":{"system":"sec-edgar","filing":"0001048477-24-000028","document":"wk-form4_1709245123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000028/wk-form4_1709245123.xml","form_type":"4"}},{"id":1610644,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-29T22:18:55.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":20220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the total number of RSUs earned pursuant to a formula based on relative total shareholder return during 2021 through 2023 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2024, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."}],"balance_after":66343,"source":{"system":"sec-edgar","filing":"0001048477-24-000028","document":"wk-form4_1709245123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000028/wk-form4_1709245123.xml","form_type":"4"}},{"id":1649893,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-12T20:04:06.000Z","date":"2023-04-28","kind":"grant","planned":false,"acquired":true,"shares":318,"price":66.878,"value":21267.204,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents the shares acquired by the reporting person on April 28, 2023, pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":46123,"source":{"system":"sec-edgar","filing":"0001048477-24-000006","document":"wk-form5_1707768227.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000006/wk-form5_1707768227.xml","form_type":"5"}},{"id":1841328,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-30T15:35:59.000Z","date":"2023-06-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":576,"price":88.93,"value":51223.68,"ownership":{"direct":true},"balance_after":45805,"source":{"system":"sec-edgar","filing":"0001048477-23-000023","document":"wk-form4_1688139350.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847723000023/wk-form4_1688139350.xml","form_type":"4"}},{"id":1841327,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-30T15:35:59.000Z","date":"2023-06-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":4602,"price":88.93,"value":409255.86,"ownership":{"direct":true},"balance_after":46381,"source":{"system":"sec-edgar","filing":"0001048477-23-000023","document":"wk-form4_1688139350.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847723000023/wk-form4_1688139350.xml","form_type":"4"}},{"id":1841326,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-30T15:35:59.000Z","date":"2023-06-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":4602,"price":88.93,"value":409255.86,"ownership":{"direct":true},"balance_after":50983,"source":{"system":"sec-edgar","filing":"0001048477-23-000023","document":"wk-form4_1688139350.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847723000023/wk-form4_1688139350.xml","form_type":"4"}},{"id":1948011,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2023-03-18T01:42:21.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":21970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests 12/48th on March 15, 2024 and 1/48th on the 15th day of each month thereafter."}],"balance_after":21970,"derivative":{"exercise_price":87.74,"exercise_date":"2024-03-15","expiration_date":"2033-03-14","underlying":"Common Stock","underlying_shares":21970},"source":{"system":"sec-edgar","filing":"0001567619-23-005297","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761923005297/doc1.xml","form_type":"4"}},{"id":1948010,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-18T01:42:21.000Z","date":"2023-03-16","kind":"tax_withholding","acquired":false,"shares":3973,"price":93.41,"value":371117.93,"ownership":{"direct":true},"balance_after":55585,"source":{"system":"sec-edgar","filing":"0001567619-23-005297","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761923005297/doc1.xml","form_type":"4"}},{"id":1948009,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-18T01:42:21.000Z","date":"2023-03-15","kind":"tax_withholding","acquired":false,"shares":2708,"price":87.74,"value":237599.92,"ownership":{"direct":true},"balance_after":59558,"source":{"system":"sec-edgar","filing":"0001567619-23-005297","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761923005297/doc1.xml","form_type":"4"}},{"id":1948008,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-18T01:42:21.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":9630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on March 15, 2023. Price not applicable."}],"balance_after":62266,"source":{"system":"sec-edgar","filing":"0001567619-23-005297","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761923005297/doc1.xml","form_type":"4"}},{"id":1980557,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-02T21:10:40.000Z","date":"2023-02-28","kind":"grant","acquired":true,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: approximately 20% vests on March 16, 2023 and approximately 80% vests on June 29, 2023, subject to the reporting person's continued service through such dates, subject to earlier vesting upon certain events."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represents the total number of RSUs earned pursuant to a formula based on non-GAAP income over three, one-year periods spanning 2020 through 2022 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."}],"balance_after":52636,"source":{"system":"sec-edgar","filing":"0001209191-23-014617","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000120919123014617/doc4.xml","form_type":"4"}},{"id":1980556,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-02T21:10:40.000Z","date":"2023-02-28","kind":"grant","acquired":true,"shares":10980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: approximately 20% vests on March 16, 2023 and approximately 80% vests on June 29, 2023, subject to the reporting person's continued service through such dates, subject to earlier vesting upon certain events."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the total number of RSUs earned pursuant to a formula based on the number and nature of strategic goals achieved during 2020 through 2022 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."}],"balance_after":51386,"source":{"system":"sec-edgar","filing":"0001209191-23-014617","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000120919123014617/doc4.xml","form_type":"4"}},{"id":1980555,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-02T21:10:40.000Z","date":"2023-02-28","kind":"grant","acquired":true,"shares":12660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the total number of RSUs earned pursuant to a formula based on relative total shareholder return during 2020 through 2022 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: approximately 20% vests on March 16, 2023 and approximately 80% vests on June 29, 2023, subject to the reporting person's continued service through such dates, subject to earlier vesting upon certain events."}],"balance_after":40406,"source":{"system":"sec-edgar","filing":"0001209191-23-014617","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000120919123014617/doc4.xml","form_type":"4"}},{"id":2053965,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2023-01-18T02:57:08.000Z","date":"2023-01-13","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 14, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":5000,"derivative":{"exercise_price":63.1,"exercise_date":"2014-12-04","expiration_date":"2024-06-03","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001567619-23-000965","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761923000965/doc1.xml","form_type":"4"}},{"id":2053964,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-01-18T02:57:08.000Z","date":"2023-01-13","kind":"sale","acquired":false,"shares":2500,"price":114.5,"value":286250.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 14, 2022."}],"balance_after":27746,"source":{"system":"sec-edgar","filing":"0001567619-23-000965","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761923000965/doc1.xml","form_type":"4"}},{"id":2053963,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-01-18T02:57:08.000Z","date":"2023-01-13","kind":"exercise","acquired":true,"shares":2500,"price":63.1,"value":157750.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 14, 2022."}],"balance_after":30246,"source":{"system":"sec-edgar","filing":"0001567619-23-000965","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761923000965/doc1.xml","form_type":"4"}},{"id":2085457,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2022-12-15T23:22:45.000Z","date":"2022-12-13","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 14, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":7500,"derivative":{"exercise_price":63.1,"exercise_date":"2014-12-04","expiration_date":"2024-06-03","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001567619-22-021667","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922021667/doc1.xml","form_type":"4"}},{"id":2085456,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-15T23:22:45.000Z","date":"2022-12-13","kind":"sale","acquired":false,"shares":2500,"price":107.5,"value":268750.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 14, 2022."}],"balance_after":27746,"source":{"system":"sec-edgar","filing":"0001567619-22-021667","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922021667/doc1.xml","form_type":"4"}},{"id":2085455,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-15T23:22:45.000Z","date":"2022-12-13","kind":"exercise","acquired":true,"shares":2500,"price":63.1,"value":157750.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 14, 2022."}],"balance_after":30246,"source":{"system":"sec-edgar","filing":"0001567619-22-021667","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922021667/doc1.xml","form_type":"4"}},{"id":2094841,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2022-12-07T02:29:18.000Z","date":"2022-12-02","kind":"exercise","acquired":false,"shares":3761,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 14, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":0,"derivative":{"exercise_price":67.81,"exercise_date":"2013-11-15","expiration_date":"2023-05-14","underlying":"Common Stock","underlying_shares":3761},"source":{"system":"sec-edgar","filing":"0001567619-22-021363","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922021363/doc1.xml","form_type":"4"}},{"id":2094840,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2022-12-07T02:29:18.000Z","date":"2022-12-02","kind":"exercise","acquired":false,"shares":2139,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 14, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":0,"derivative":{"exercise_price":67.81,"exercise_date":"2013-11-15","expiration_date":"2023-05-14","underlying":"Common Stock","underlying_shares":2139},"source":{"system":"sec-edgar","filing":"0001567619-22-021363","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922021363/doc1.xml","form_type":"4"}},{"id":2094839,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-07T02:29:18.000Z","date":"2022-12-02","kind":"sale","acquired":false,"shares":3761,"price":104.5,"value":393024.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 14, 2022."}],"balance_after":27746,"source":{"system":"sec-edgar","filing":"0001567619-22-021363","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922021363/doc1.xml","form_type":"4"}},{"id":2094838,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-07T02:29:18.000Z","date":"2022-12-02","kind":"exercise","acquired":true,"shares":3761,"price":67.81,"value":255033.41,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 14, 2022."}],"balance_after":31507,"source":{"system":"sec-edgar","filing":"0001567619-22-021363","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922021363/doc1.xml","form_type":"4"}},{"id":2094837,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-07T02:29:18.000Z","date":"2022-12-02","kind":"sale","acquired":false,"shares":2139,"price":104.5,"value":223525.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 14, 2022."}],"balance_after":27746,"source":{"system":"sec-edgar","filing":"0001567619-22-021363","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922021363/doc1.xml","form_type":"4"}},{"id":2094836,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-07T02:29:18.000Z","date":"2022-12-02","kind":"exercise","acquired":true,"shares":2139,"price":67.81,"value":145045.59,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 14, 2022."}],"balance_after":29885,"source":{"system":"sec-edgar","filing":"0001567619-22-021363","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922021363/doc1.xml","form_type":"4"}},{"id":2094835,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-07T02:29:18.000Z","date":"2022-12-02","kind":"sale","acquired":false,"shares":1101,"price":104.5,"value":115054.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 14, 2022."}],"balance_after":27746,"source":{"system":"sec-edgar","filing":"0001567619-22-021363","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922021363/doc1.xml","form_type":"4"}},{"id":2103584,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2022-11-29T02:42:03.000Z","date":"2022-11-23","kind":"exercise","acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 14, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":3761,"derivative":{"exercise_price":67.81,"exercise_date":"2013-11-15","expiration_date":"2023-05-14","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001567619-22-020937","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922020937/doc1.xml","form_type":"4"}},{"id":2103583,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-11-29T02:42:03.000Z","date":"2022-11-23","kind":"sale","acquired":false,"shares":3500,"price":99.5,"value":348250.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 14, 2022."}],"balance_after":28847,"source":{"system":"sec-edgar","filing":"0001567619-22-020937","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922020937/doc1.xml","form_type":"4"}},{"id":2103582,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-11-29T02:42:03.000Z","date":"2022-11-23","kind":"exercise","acquired":true,"shares":3500,"price":67.81,"value":237335.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 14, 2022."}],"balance_after":32347,"source":{"system":"sec-edgar","filing":"0001567619-22-020937","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922020937/doc1.xml","form_type":"4"}},{"id":2103581,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-11-29T02:42:03.000Z","date":"2022-11-23","kind":"sale","acquired":false,"shares":945,"price":99.5,"value":94027.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 14, 2022."}],"balance_after":28847,"source":{"system":"sec-edgar","filing":"0001567619-22-020937","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922020937/doc1.xml","form_type":"4"}},{"id":2103580,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-11-29T02:42:03.000Z","date":"2022-11-23","kind":"sale","acquired":false,"shares":934,"price":95.09,"value":88814.06,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 14, 2022."}],"balance_after":29792,"source":{"system":"sec-edgar","filing":"0001567619-22-020937","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922020937/doc1.xml","form_type":"4"}},{"id":2191236,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2022-08-09T23:27:40.000Z","date":"2022-08-05","kind":"exercise","acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 14, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":7261,"derivative":{"exercise_price":67.81,"exercise_date":"2013-11-15","expiration_date":"2023-05-14","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001567619-22-015384","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922015384/doc1.xml","form_type":"4"}},{"id":2191235,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-09T23:27:40.000Z","date":"2022-08-05","kind":"sale","acquired":false,"shares":3500,"price":94.5,"value":330750.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 14, 2022."}],"balance_after":30726,"source":{"system":"sec-edgar","filing":"0001567619-22-015384","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922015384/doc1.xml","form_type":"4"}},{"id":2191234,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-09T23:27:40.000Z","date":"2022-08-05","kind":"exercise","acquired":true,"shares":3500,"price":67.81,"value":237335.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 14, 2022."}],"balance_after":34226,"source":{"system":"sec-edgar","filing":"0001567619-22-015384","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922015384/doc1.xml","form_type":"4"}},{"id":2208721,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-07-12T18:25:43.000Z","date":"2022-07-08","kind":"sale","acquired":false,"shares":7337,"price":89.5,"value":656661.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 14, 2022."}],"balance_after":30726,"source":{"system":"sec-edgar","filing":"0001567619-22-013907","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922013907/doc1.xml","form_type":"4"}},{"id":2217697,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-07-01T19:25:54.000Z","date":"2022-06-29","kind":"tax_withholding","acquired":false,"shares":576,"price":83.92,"value":48337.92,"ownership":{"direct":true},"balance_after":38063,"source":{"system":"sec-edgar","filing":"0001567619-22-013594","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922013594/doc1.xml","form_type":"4"}},{"id":2279631,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2022-05-06T23:45:49.000Z","date":"2022-05-04","kind":"exercise","acquired":false,"shares":9762,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Trade made pursuant to a 10b5-1 plan executed on March 14, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":0,"derivative":{"exercise_price":37.46,"exercise_date":"2012-11-08","expiration_date":"2022-05-07","underlying":"Common Stock","underlying_shares":9762},"source":{"system":"sec-edgar","filing":"0001567619-22-009717","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922009717/doc1.xml","form_type":"4"}},{"id":2279630,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2022-05-06T23:45:49.000Z","date":"2022-05-04","kind":"exercise","acquired":false,"shares":2038,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Trade made pursuant to a 10b5-1 plan executed on March 14, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":0,"derivative":{"exercise_price":37.46,"exercise_date":"2012-11-08","expiration_date":"2022-05-07","underlying":"Common Stock","underlying_shares":2038},"source":{"system":"sec-edgar","filing":"0001567619-22-009717","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922009717/doc1.xml","form_type":"4"}},{"id":2279629,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-05-06T23:45:49.000Z","date":"2022-05-04","kind":"sale","acquired":false,"shares":9762,"price":84.5,"value":824889.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Trade made pursuant to a 10b5-1 plan executed on March 14, 2022."}],"balance_after":38639,"source":{"system":"sec-edgar","filing":"0001567619-22-009717","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922009717/doc1.xml","form_type":"4"}},{"id":2279628,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-05-06T23:45:49.000Z","date":"2022-05-04","kind":"exercise","acquired":true,"shares":9762,"price":37.46,"value":365684.52,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Trade made pursuant to a 10b5-1 plan executed on March 14, 2022."}],"balance_after":48401,"source":{"system":"sec-edgar","filing":"0001567619-22-009717","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922009717/doc1.xml","form_type":"4"}},{"id":2279627,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-05-06T23:45:49.000Z","date":"2022-05-04","kind":"sale","acquired":false,"shares":2038,"price":84.5,"value":172211.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Trade made pursuant to a 10b5-1 plan executed on March 14, 2022."}],"balance_after":38639,"source":{"system":"sec-edgar","filing":"0001567619-22-009717","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922009717/doc1.xml","form_type":"4"}},{"id":2279626,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-05-06T23:45:49.000Z","date":"2022-05-04","kind":"exercise","acquired":true,"shares":2038,"price":37.46,"value":76343.48,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Trade made pursuant to a 10b5-1 plan executed on March 14, 2022."}],"balance_after":40677,"source":{"system":"sec-edgar","filing":"0001567619-22-009717","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922009717/doc1.xml","form_type":"4"}},{"id":2279625,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-05-06T23:45:49.000Z","date":"2022-04-29","kind":"grant","acquired":true,"shares":340,"price":62.407,"value":21218.38,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents shares acquired by the reporting person on April 29, 2022, pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":38639,"source":{"system":"sec-edgar","filing":"0001567619-22-009717","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922009717/doc1.xml","form_type":"4"}},{"id":2328545,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2022-03-18T01:38:25.000Z","date":"2022-03-15","kind":"grant","acquired":true,"shares":26520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests 12/48th on March 15, 2023 and 1/48th on the 15th day of each month thereafter."}],"balance_after":26520,"derivative":{"exercise_price":78.27,"exercise_date":"2023-03-15","expiration_date":"2032-03-14","underlying":"Common Stock","underlying_shares":26520},"source":{"system":"sec-edgar","filing":"0001567619-22-007185","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922007185/doc1.xml","form_type":"4"}},{"id":2328544,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-18T01:38:25.000Z","date":"2022-03-16","kind":"tax_withholding","acquired":false,"shares":582,"price":80.72,"value":46979.04,"ownership":{"direct":true},"balance_after":38299,"source":{"system":"sec-edgar","filing":"0001567619-22-007185","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922007185/doc1.xml","form_type":"4"}},{"id":2328543,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-18T01:38:25.000Z","date":"2022-03-15","kind":"tax_withholding","acquired":false,"shares":1868,"price":78.27,"value":146208.36,"ownership":{"direct":true},"balance_after":38881,"source":{"system":"sec-edgar","filing":"0001567619-22-007185","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922007185/doc1.xml","form_type":"4"}},{"id":2328542,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-18T01:38:25.000Z","date":"2022-03-15","kind":"grant","acquired":true,"shares":11040,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on March 15, 2022. Price not applicable."}],"balance_after":40749,"source":{"system":"sec-edgar","filing":"0001567619-22-007185","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922007185/doc1.xml","form_type":"4"}},{"id":2410424,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-08T01:48:06.000Z","date":"2022-02-03","kind":"tax_withholding","acquired":false,"shares":1072,"price":87.77,"value":94089.44,"ownership":{"direct":true},"balance_after":29709,"source":{"system":"sec-edgar","filing":"0001567619-22-002765","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922002765/doc1.xml","form_type":"4"}},{"id":2650641,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-07-01T00:18:11.000Z","date":"2021-06-29","kind":"tax_withholding","acquired":false,"shares":576,"price":83.46,"value":48072.96,"ownership":{"direct":true},"balance_after":30781,"source":{"system":"sec-edgar","filing":"0001567619-21-012800","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921012800/doc1.xml","form_type":"4"}},{"id":2719089,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2021-05-11T23:42:54.000Z","date":"2021-05-07","kind":"exercise","acquired":false,"shares":6709,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Trade made pursuant to a 10b5-1 plan executed on January 29, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":0,"derivative":{"exercise_price":28.23,"exercise_date":"2011-12-01","expiration_date":"2021-05-30","underlying":"Common Stock","underlying_shares":6709},"source":{"system":"sec-edgar","filing":"0001567619-21-009606","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921009606/doc1.xml","form_type":"4"}},{"id":2719088,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-05-11T23:42:54.000Z","date":"2021-05-07","kind":"sale","acquired":false,"shares":6709,"price":79.5,"value":533365.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Trade made pursuant to a 10b5-1 plan executed on January 29, 2021."}],"balance_after":31357,"source":{"system":"sec-edgar","filing":"0001567619-21-009606","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921009606/doc1.xml","form_type":"4"}},{"id":2719087,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-05-11T23:42:54.000Z","date":"2021-05-07","kind":"exercise","acquired":true,"shares":6709,"price":28.23,"value":189395.07,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Trade made pursuant to a 10b5-1 plan executed on January 29, 2021."}],"balance_after":38066,"source":{"system":"sec-edgar","filing":"0001567619-21-009606","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921009606/doc1.xml","form_type":"4"}},{"id":2719086,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-05-11T23:42:54.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":341,"price":62.407,"value":21280.787,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents shares acquired by the reporting person on April 30, 2021, pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":31357,"source":{"system":"sec-edgar","filing":"0001567619-21-009606","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921009606/doc1.xml","form_type":"4"}},{"id":2762189,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-04-02T23:35:06.000Z","date":"2021-04-01","kind":"sale","acquired":false,"shares":5692,"price":76.3,"value":434299.6,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on January 29, 2021."}],"balance_after":31016,"source":{"system":"sec-edgar","filing":"0001567619-21-007548","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921007548/doc1.xml","form_type":"4"}},{"id":2775243,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-24T01:22:04.000Z","date":"2021-03-22","kind":"tax_withholding","acquired":false,"shares":516,"price":78.52,"value":40516.32,"ownership":{"direct":true},"balance_after":36708,"source":{"system":"sec-edgar","filing":"0001567619-21-006822","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921006822/doc1.xml","form_type":"4"}},{"id":2783479,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2021-03-18T01:39:01.000Z","date":"2021-03-15","kind":"grant","acquired":true,"shares":24890,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Option grant vests 12/48th on March 15, 2022 and 1/48th on the 15th day of each month thereafter."}],"balance_after":24890,"derivative":{"exercise_price":78.39,"exercise_date":"2022-03-15","expiration_date":"2031-03-14","underlying":"Common Stock","underlying_shares":24890},"source":{"system":"sec-edgar","filing":"0001567619-21-006555","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921006555/doc1.xml","form_type":"4"}},{"id":2783478,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-18T01:39:01.000Z","date":"2021-03-16","kind":"tax_withholding","acquired":false,"shares":582,"price":77.21,"value":44936.22,"ownership":{"direct":true},"balance_after":37224,"source":{"system":"sec-edgar","filing":"0001567619-21-006555","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921006555/doc1.xml","form_type":"4"}},{"id":2783477,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-18T01:39:01.000Z","date":"2021-03-15","kind":"tax_withholding","acquired":false,"shares":994,"price":78.39,"value":77919.66,"ownership":{"direct":true},"balance_after":37806,"source":{"system":"sec-edgar","filing":"0001567619-21-006555","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921006555/doc1.xml","form_type":"4"}},{"id":2783476,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-18T01:39:01.000Z","date":"2021-03-15","kind":"grant","acquired":true,"shares":10110,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on March 15, 2021.  Price not applicable."}],"balance_after":38800,"source":{"system":"sec-edgar","filing":"0001567619-21-006555","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921006555/doc1.xml","form_type":"4"}},{"id":2864073,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-12T20:10:55.000Z","date":"2020-10-30","kind":"grant","acquired":true,"shares":17,"price":62.586,"value":1063.962,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents shares acquired by the reporting person on October 30, 2020, pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":29761,"source":{"system":"sec-edgar","filing":"0001567619-21-003407","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921003407/doc1.xml","form_type":"5"}},{"id":2879530,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-05T00:48:46.000Z","date":"2021-02-03","kind":"tax_withholding","acquired":false,"shares":1071,"price":82.82,"value":88700.22,"ownership":{"direct":true},"balance_after":28673,"source":{"system":"sec-edgar","filing":"0001567619-21-002227","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921002227/doc1.xml","form_type":"4"}},{"id":3096931,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2020-07-01T01:48:18.000Z","date":"2020-06-29","kind":"grant","acquired":true,"shares":13230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"Option grant vests 12/48th on June 29, 2021 and 1/48th on the 29th day of each month thereafter."}],"balance_after":13230,"derivative":{"exercise_price":122.18,"exercise_date":"2021-06-29","expiration_date":"2030-06-28","underlying":"Common Stock","underlying_shares":13230},"source":{"system":"sec-edgar","filing":"0001567619-20-012731","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920012731/doc1.xml","form_type":"4"}},{"id":3096930,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-07-01T01:48:18.000Z","date":"2020-06-29","kind":"grant","acquired":true,"shares":4640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units granted on June 29, 2020. Price not applicable."}],"balance_after":29744,"source":{"system":"sec-edgar","filing":"0001567619-20-012731","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920012731/doc1.xml","form_type":"4"}},{"id":3096929,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-07-01T01:48:18.000Z","date":"2020-04-30","kind":"grant","acquired":true,"shares":323,"price":62.586,"value":20215.278,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents shares acquired by the reporting person on April 30, 2020, pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":25104,"source":{"system":"sec-edgar","filing":"0001567619-20-012731","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920012731/doc1.xml","form_type":"4"}},{"id":3196819,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Acting CFO"}}],"security":"Common Stock","published_at":"2020-03-25T01:07:26.000Z","date":"2020-03-20","kind":"tax_withholding","acquired":false,"shares":414,"price":73.05,"value":30242.7,"ownership":{"direct":true},"balance_after":24781,"source":{"system":"sec-edgar","filing":"0001567619-20-006974","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920006974/doc1.xml","form_type":"4"}},{"id":3206297,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Acting CFO"}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2020-03-18T01:22:24.000Z","date":"2020-03-16","kind":"grant","acquired":true,"shares":9600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Option grant vests 12/48th on March 16, 2021 and 1/48th on the 16th day of each month thereafter."}],"balance_after":9600,"derivative":{"exercise_price":73.82,"exercise_date":"2021-03-16","expiration_date":"2030-03-15","underlying":"Common Stock","underlying_shares":9600},"source":{"system":"sec-edgar","filing":"0001567619-20-006637","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920006637/doc1.xml","form_type":"4"}},{"id":3206296,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Acting CFO"}}],"security":"Common Stock","published_at":"2020-03-18T01:22:24.000Z","date":"2020-03-16","kind":"grant","acquired":true,"shares":6730,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on March 16, 2020. Price not applicable."}],"balance_after":25195,"source":{"system":"sec-edgar","filing":"0001567619-20-006637","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920006637/doc1.xml","form_type":"4"}},{"id":3206295,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Acting CFO"}}],"security":"Common Stock","published_at":"2020-03-18T01:22:24.000Z","date":"2020-03-13","kind":"tax_withholding","acquired":false,"shares":1303,"price":84.5,"value":110103.5,"ownership":{"direct":true},"balance_after":18465,"source":{"system":"sec-edgar","filing":"0001567619-20-006637","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920006637/doc1.xml","form_type":"4"}},{"id":3292434,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Acting CFO"}}],"security":"Common Stock","published_at":"2020-02-05T01:19:12.000Z","date":"2020-02-03","kind":"grant","acquired":true,"shares":5800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units granted on February 3, 2020. Price not applicable."}],"balance_after":19768,"source":{"system":"sec-edgar","filing":"0001567619-20-002150","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920002150/doc1.xml","form_type":"4"}},{"id":3292433,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Acting CFO"}}],"security":"Common Stock","published_at":"2020-02-05T01:19:12.000Z","date":"2019-10-31","kind":"grant","acquired":true,"shares":9,"price":62.229,"value":560.061,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents shares acquired by the reporting person on October 31, 2019, pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":13968,"source":{"system":"sec-edgar","filing":"0001567619-20-002150","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920002150/doc1.xml","form_type":"4"}},{"id":3497527,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance and CAO"}}],"security":"Common Stock","published_at":"2019-06-07T22:48:50.000Z","date":"2019-04-30","kind":"grant","acquired":true,"shares":299,"price":68.782,"value":20565.818,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents shares acquired by the reporting person on April 30, 2019, pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":13959,"source":{"system":"sec-edgar","filing":"0001567619-19-013091","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761919013091/doc1.xml","form_type":"4"}},{"id":3559511,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2019-04-09T22:12:01.000Z","date":"2019-04-05","kind":"sale","acquired":false,"shares":2953,"price":94,"value":277582.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This trade is made pursuant to a 10b5-1 plan executed on March 12, 2019."}],"balance_after":13660,"source":{"system":"sec-edgar","filing":"0001567619-19-008642","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761919008642/doc1.xml","form_type":"4"}},{"id":3578836,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2019-03-27T00:37:15.000Z","date":"2019-03-22","kind":"tax_withholding","acquired":false,"shares":415,"price":88.05,"value":36540.75,"ownership":{"direct":true},"balance_after":16613,"source":{"system":"sec-edgar","filing":"0001567619-19-007688","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761919007688/doc1.xml","form_type":"4"}},{"id":3588380,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corporate Controller"}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2019-03-20T00:26:36.000Z","date":"2019-03-15","kind":"grant","acquired":true,"shares":9650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Option grant vests 12/48th on March 15, 2020 and 1/48th on the 15th day of each month thereafter."}],"balance_after":9650,"derivative":{"exercise_price":94.53,"exercise_date":"2020-03-15","expiration_date":"2029-03-14","underlying":"Common Stock","underlying_shares":9650},"source":{"system":"sec-edgar","filing":"0001567619-19-007255","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761919007255/doc1.xml","form_type":"4"}},{"id":3588379,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2019-03-20T00:26:36.000Z","date":"2019-03-15","kind":"grant","acquired":true,"shares":5780,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on March 15, 2019. Price not applicable."}],"balance_after":17028,"source":{"system":"sec-edgar","filing":"0001567619-19-007255","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761919007255/doc1.xml","form_type":"4"}},{"id":3588378,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2019-03-20T00:26:36.000Z","date":"2019-03-15","kind":"tax_withholding","acquired":false,"shares":1149,"price":94.53,"value":108614.97,"ownership":{"direct":true},"balance_after":11248,"source":{"system":"sec-edgar","filing":"0001567619-19-007255","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761919007255/doc1.xml","form_type":"4"}},{"id":3723586,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2018-12-20T22:50:23.000Z","date":"2018-10-31","kind":"grant","acquired":true,"shares":22,"price":68.782,"value":1513.204,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents shares acquired by the reporting person on October 31, 2018, pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":12397,"source":{"system":"sec-edgar","filing":"0001567619-18-008457","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761918008457/doc1.xml","form_type":"4"}}],"next_cursor":"2018-12-20T22:50:23.000000Z,3723586"}